Safety, effectiveness and feasibility of treating Chronic Active Hepatitis C Virus (HCV) Infection with direct-acting antivirals (DAAs) in patients with Multidrug-Resistant Tuberculosis (MDR-TB)

Principal investigator

Helena Huerga
Purpose of study
Purpose of study

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline

Documents

Publications

No publications recorded
Previous study
Next study